Protego Biopharma's last reported valuation, Mar 2025. Nothing priced has surfaced since.
- ·The complete investor list: 12 names
- ·Watch Protego Biopharma: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Protego Biopharma funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Early Stage VC | $32.9M | ▮ | ▮ |
| Oct 2021 | Later Stage VC | $51.0M | ▮ | ▮ |
| Dec 2019 | Seed Round | $1.0M | ▮ | ▮ |
Membership and data by Private Market View
Protego Biopharma valuation
Protego Biopharma's last reported valuation was $217 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.
How much has Protego Biopharma raised?
Protego Biopharma has raised $182 million in total; 3 of its rounds are on record, from 2019 on. The largest on record was a $51 million later-stage round in Oct 2021; the most recent was a $32.9 million early-stage round in Oct 2025.
Protego Biopharma has filed 3 Form Ds with the SEC since 2019, most recently in Dec 2025 ($32.9 million sold to 18 investors).
How Protego Biopharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Protego Biopharma, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Protego Biopharma
- What is Protego Biopharma worth?
- Protego Biopharma is valued at $216.5M as of Oct 2026. Protego Biopharma's last reported valuation, Mar 2025. Nothing priced has surfaced since.
- How much has Protego Biopharma raised?
- Protego Biopharma has raised $182.1M in total funding across 3 recorded rounds.
- When did Protego Biopharma last raise?
- Protego Biopharma last raised in Oct 2025 (Early Stage VC), raising $32.9M.